Skip to main content

Table 1 Values of lysis experiments as depicted in Fig. 3 and TEM experiments as depicted in Fig. 4

From: In vitro examination of the thrombolytic efficacy of tenecteplase and therapeutic ultrasound compared to rt-PA

  A
control
B
rt-PA
C
rt-PA + US
D
TNK
E
TNK + US
weight loss ± SD [%] 17.3 ± 7.4 28.3 ± 9.6 31.6 ± 10 34.5 ± 8 38.1 ± 6.7
area covered by fibrin ± SD [%] 58 ± 5.2 54.7 ± 3.6 52.9 ± 6.5 42.3 ± 6 45.1 ± 2.3
  1. Results for measured relative clot weight loss of different treatment groups (A-E) as well as for relative area covered by fibrin in TEM for the different treatment strategies are combined. SD: standard deviation from the mean. TNK: tenecteplase; US: color-coded sonography (2 MHz, 0.179 W/cm2)